NASDAQ · ABVX
Abivax SA
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for ABVX: Dec 21, 2026
Abivax SA American Depositary Shares is estimated to report earnings on 12/21/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 2 analysts' forecasts, the consensus EPS forecast for the quarter is $-1.27. The reported EPS for the same quarter last year was $-2.45.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-1.27 | $-0.89 | $-1.65 | 2 |
| Dec 2026 | $-1.24 | $-0.94 | $-1.54 | 2 |
| Mar 2027 | $-1.32 | $-0.97 | $-1.67 | 2 |
| Jun 2027 | $-1.42 | $-1.13 | $-1.70 | 2 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
BNK Invest · RTTNews · Zacks · The Motley Fool- BNK Invest · Oct 6, 11:07 AM EDTNotable ETF Inflow Detected – VEA, GFL, ABVX, SHOPLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard FTSE Developed Markets ETF (Symbol: VEA) where we have detected an approximate $1.0 billion dollar inflow — that's a 0.4% increase week ove
- RTTNews · Sep 22, 5:16 AM EDTAbivax H1 Net Loss Widens; Plans Obefazimod NDA For Ulcerative Colitis By End Of 2026(RTTNews) – Abivax SA (ABVX, ABVX.PA), a clinical-stage biotechnology company, reported first-half 2026 financial results, reflecting a wider net loss, and provided an update on near-term milestones. The company also announced corporate appointments effective immediately.
- Zacks · Sep 18, 12:31 PM EDT4 Biotech Stocks to Watch as Potential Takeover TargetsBiotech M&A surges in 2026, putting ABVX, IOVA, VKTX and BCRX on watchlists, as drugmakers seek late-stage and commercial assets.
- Zacks · Sep 8, 12:00 PM EDTAbivax SA Sponsored ADR (ABVX) Upgraded to Buy: Here's WhyAbivax SA Sponsored ADR (ABVX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- BNK Invest · Sep 8, 10:54 AM EDTVanguard FTSE Developed Markets ETF Experiences Big InflowLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard FTSE Developed Markets ETF (Symbol: VEA) where we have detected an approximate $872.2 million dollar inflow — that's a 0.4% increase week o
- BNK Invest · Aug 6, 11:22 AM EDTVGK, ABVX, BORR: Large Outflows Detected at ETFLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard FTSE Europe ETF (Symbol: VGK) where we have detected an approximate $236.3 million dollar outflow — that's a 0.8% decrease week over week
- Zacks · Jul 10, 9:55 AM EDTShould You Buy Abivax SA Sponsored ADR (ABVX) After Golden Cross?When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
- The Motley Fool · Jul 7, 7:35 PM EDT3 Soaring Stocks That May Have More Upside AheadAbivax's shares could rise even further as it advances a candidate poised to disrupt a large market.
- MarketBeat · Jul 7, 12:25 PM EDTAbivax: Wall Street Catches Up to the DataShares of Abivax (NASDAQ: ABVX) were up more than 40% in the month ending July 6, after the company announced positive results from its late-stage (Phase 3) trial of its lead candidate, Obefazimod, which is being designed as a long-term maintenance treatment for ulcerative coli
- RTTNews · Jul 1, 10:31 AM EDTAbivax Prices Oversubscribed $800M ADS Offering To Support Obefazimod Development(RTTNews) – Abivax SA (ABVX) announced the pricing of an upsized and oversubscribed public offering of 6.4 million American Depositary Shares (ADSs) at $125.00 per ADS, raising approximately $800 million (€702 million).
- RTTNews · Jul 1, 8:58 AM EDTABIVAX Announces Pricing Of $800 Mln Offering Of ADS(RTTNews) – Wednesday, ABIVAX Société Anonyme (ABVX) announced the pricing of an underwritten public offering of 6.4 million American Depositary Shares or ADSs, each representing one ordinary share, 0.01 nominal value per share, of the company, for $125 per ADS.
- RTTNews · Jul 1, 4:53 AM EDTAbivax Requests Trading Halt On Euronext Paris For $600 Mln ADS Offering(RTTNews) – Abivax SA (ABVX, ABVX.PA), a clinical-stage biotechnology company, announced on Wednesday that trading of its shares on the Euronext Paris market will be temporarily halted, at the company's request, from the opening of the market at 9:00 a.m. CEST, related to the ADS
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for Abivax SA from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.